Agreement between Ascendis Pharma A/S and ST is for the exclusive distribution and commercialisation of three Ascendis Pharma endocrinology therapiesTwo of the therapies are already internationally.
/PRNewswire/ Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) has added three new endocrinology therapies to its specialist.
Specialised Therapeutics Asia Pte Ltd. has signed a license deal with CanariaBio Inc., acquiring the exclusive license to a new monoclonal antibody therapy for patients with ovarian cancer in.
Specialised Therapeutics signs exclusive license agreement with CanariaBio for new ovarian cancer therapy asiabulletin.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asiabulletin.com Daily Mail and Mail on Sunday newspapers.
Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd (ST) has signed a license deal with Korea-based CanariaBio Inc., acquiring the exclusive license to a new monoclonal antibody therapy for patients with ovarian cancer in Australia, New Zealand and in select Southeast Asian countries.